+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

P

Actively Recruiting

Researchers are evaluating Veregen 10% ointment as a new herbal topical treatment for adults with mild to moderate Actinic Keratosis AK on the face and scalp. The study aims to show that Veregen ointment is superior to a placebo ointment in completely clearing a defined treatment area of AK lesions. This randomized, placebo-controlled, double-blind Phase 3 trial focuses on patients aged 18 and older with specific AK lesion characteristics.

Age: 18Years +All GendersPhase 3
1 location